If you would like to submit a blog post for consideration, please email firstname.lastname@example.org
This month I am sharing a fascinating paper from the Nature journal that expands – and challenges – our understanding of the power and utility of artificial intelligence (AI) in skin cancer diagnosis. Continue reading “[2 min read] Power and utility of AI in skin cancer diagnosis | Prof David Wilkinson”
Skin cancer has been dubbed Australia’s ‘national cancer’, accounting for four times as many diagnoses as all other cancers put together. Finding ways to prevent skin cancer is a hot topic, and was the subject of a study conducted by a research team at the University of Sydney. As it is known that UV radiation causes DNA damage and also suppresses the innate immune response of the skin, the researchers sought to find compounds that could negate this process – specifically vitamin B3.
For a really useful, powerful and insightful overview of the situation with skin cancer in Australia, I recommend a new article published in the MJA to “celebrate” National Skin Cancer Action Week. Continue reading “[8 min read] Burden of skin cancer in Australia | Prof David Wilkinson”
Do you use LED phototherapy in your practice, or do you wish to utilise its full potential in treating a range of skin concerns? In this webinar, Skin Cancer and Aesthetic Medicine Doctor Di King shares how light emitting diode (LED) can be used to treat a range of common dermatological presentations, including acne, superficial skin lesions, and wound healing. Continue reading “[WEBINAR] LED phototherapy in skin cancer, general dermatology and aesthetic medicine”
How do you manage patients aged 85 and older with keratinocyte carcinoma? An assessment of a patient’s functional status may help to estimate which elderly patients will benefit from surgical treatment for keratinocyte carcinoma. However, predictive short-term survival in this population has not been determined. Continue reading “[2 min read] Does functional status predict survival in elderly keratinocyte carcinoma patients?”
We all use biopsy to confirm the clinical diagnosis of basal cell carcinoma (BCC), to determine the sub-type of BCC, and hence to plan the formal treatment – this is usually by excision with appropriate margins, but of course we also consider other destructive methods or topical treatments.
Colleagues will be aware of the technology that is reflectance confocal microscopy (RCM). This is special imaging of the sub-structure of the skin, typically available in specialist centres, and can be used to identify BCC sub type, and to map margins. Continue reading “[2 min read] Biopsy vs reflectance confocal microscopy in diagnosing BCC | Prof David Wilkinson”
Nodular basal cell carcinoma (BCC) is most often treated with surgical excision. However, interest is increasing in minimally invasive treatments for these low-risk skin cancers. A new study reviewed the effectiveness of surgical excision compared with curettage and imiquimod cream in treating nodular BCC. Continue reading “[2 min read] Surgery vs curettage & imiquimod for nodular BCC”
Treating actinic keratosis is very common in general practice, and especially so in primary care skin cancer medicine. Many patients require treatment of both individual lesions (for example, by cryotherapy) and of the whole field that is affected (for example, the whole face, using a topical treatment, or a field treatment more generally). Continue reading “[2 min read] Field treatments for actinic keratosis | Prof David Wilkinson”
How effective and safe is photodynamic therapy in treating Bowen’s disease? Bowen’s disease is an intraepidermal squamous cell carcinoma (SCC). There are several alternatives for treatment of Bowen’s disease, including photodynamic therapy. A new study investigated the efficacy and safety of photodynamic therapy in treating the skin condition. Continue reading “[3 min read] Photodynamic therapy for Bowen’s disease”
In this month’s skin cancer update video, Professor Giuseppe Argenziano talks about the three possible outcomes that can be reached after you check a lesion: Excise, monitor, or do nothing. In most cases, lesions are either deemed suspicious and excised, or deemed safe and the patient goes home. Giuseppe warns that the other option – monitoring the lesion at follow-up appointments – should be used with caution and in limited cases. He goes through the scenarios in which monitoring the lesion is a good choice and how doctors can go about the follow-up procedure. Continue reading “[5 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [July 2020]”